Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan.
Department of Medical Informatics, Niigata University Medical and Dental Hospital, Niigata, Japan.
Gastric Cancer. 2017 Sep;20(5):834-842. doi: 10.1007/s10120-017-0699-4. Epub 2017 Feb 15.
The Japanese Gastric Cancer Association (JGCA) initiated a new nationwide gastric cancer registry in 2008 and reported the treatment outcomes of patients with primary gastric cancer who underwent surgical therapy in 2001 and 2003. However, the outcomes of endoscopic therapy have not been reported yet.
The JGCA conducted a retrospective nationwide registry in 2013 to investigate the short-term and long-term outcomes of endoscopic mucosal resection or endoscopic submucosal dissection in patients with gastric cancer treated from January 2004 through December 2006. This registry used a computerized database with terminology in accordance with the JGCA classification (13th and 14th editions) and the Japanese Gastric Cancer Treatment Guidelines from 2010.
Accurate data on 12,647 patients were collected from 126 participating hospitals and analyzed. The treatment procedure was endoscopic submucosal dissection in 81% of the patients and endoscopic mucosal resection in 19%. En bloc and R0 resections were achieved in 89% and 79% of the patients respectively. The total proportion of patients who underwent curative resection was 69.2%; 43.8% of patients underwent curative resection for absolute indication lesions, and 25.4% underwent curative resection for expanded indication lesions. Emergency surgery was performed to treat bleeding or perforation in very few patients (0.3% and 0.4% respectively). The 5-year follow-up rate after endoscopic resection was 70%. The 5-year overall survival rate was 91.6% in patients with absolute indications and 90.3% in patients with expanded indications after curative resection and 86.5% in patients who underwent noncurative resection. The 5-year disease-specific survival rates were 99.9%, 99.7%, and 98.7% in patients with absolute indications who underwent curative resection, patients with expanded indications who underwent curative resection, and patients who underwent noncurative resection respectively.
Endoscopic resection of gastric cancer resulted in favorable short-term and long-term outcomes nationwide in Japan. Further efforts to increase the follow-up rate are needed.
日本胃癌协会(JGCA)于 2008 年启动了一项新的全国性胃癌登记处,并报告了 2001 年和 2003 年接受手术治疗的原发性胃癌患者的治疗结果。然而,内镜治疗的结果尚未报告。
JGCA 于 2013 年进行了一项回顾性全国登记,以调查 2004 年 1 月至 2006 年 12 月期间接受内镜黏膜切除术或内镜黏膜下剥离术治疗的胃癌患者的短期和长期结果。该登记使用了一个计算机数据库,术语符合 JGCA 分类(第 13 版和第 14 版)和 2010 年日本胃癌治疗指南。
从 126 家参与医院收集了 12647 名患者的准确数据并进行了分析。治疗程序是内镜黏膜下剥离术占 81%,内镜黏膜切除术占 19%。整块和 R0 切除分别在 89%和 79%的患者中实现。行根治性切除术的患者总比例为 69.2%;43.8%的患者因绝对适应证病变行根治性切除术,25.4%的患者因扩大适应证病变行根治性切除术。极少数患者(分别为 0.3%和 0.4%)因出血或穿孔而行急诊手术。内镜切除后的 5 年随访率为 70%。绝对适应证患者的 5 年总生存率为 91.6%,根治性切除后的扩大适应证患者为 90.3%,非根治性切除患者为 86.5%。绝对适应证患者根治性切除、扩大适应证患者根治性切除和非根治性切除患者的 5 年疾病特异性生存率分别为 99.9%、99.7%和 98.7%。
日本全国范围内,内镜治疗胃癌取得了良好的短期和长期效果。需要进一步努力提高随访率。